Healthcare Industry News: LifeScan
News Release - June 29, 2010
New Lancing System Delivers More Comfortable Blood Glucose Testing(1)OneTouch® Delica Lancing System Uses Proprietary Lancet and Precise Advanced Glide Control System for Gentle Testing
MILPITAS, Calif., June 29 -- (Healthcare Sales & Marketing Network) -- LifeScan, Inc., makers of the top-selling OneTouch® Brand Blood Glucose Monitoring Systems, has introduced the new OneTouch® Delica™ Lancing System. Now nationally available, it is designed to provide more comfortable blood glucose testing for the 18 million Americans diagnosed with diabetes.
For many of these individuals, regular blood glucose monitoring, as recommended by their healthcare professional, is a key part of their daily diabetes management and can help prevent or delay serious complications. But the pain of lancing -- which involves piercing the skin with a needle (lancet) to draw a small blood sample -- can be a barrier. In fact, of those people who quit testing their blood glucose each year, nearly 1 in 6 cite the pain of lancing as the reason.(2)
The OneTouch Delica System may help patients overcome this barrier. "It's important for people with diabetes to regularly test their blood glucose, particularly those using insulin, who typically need to test several times a day," said Dr. Marc Steinberg,* a diabetes specialist who himself has had type 1 diabetes for 38 years. "A device like the OneTouch Delica System can significantly reduce the pain of lancing for many people. This can help them feel more comfortable about testing and makes it easier to get valuable information that can improve their day-to-day diabetes self management."
In a clinical study of nearly 200 people with diabetes, 4 out of 5 reported the OneTouch Delica Lancing System was virtually painless and the most comfortable lancing device they have ever used. 96% said it was easy to use and 84% reported that it was quiet, and provided a discreet lancing solution.
To provide improved comfort, the OneTouch Delica System features a new, proprietary 33 gauge lancet that is 40% thinner than current industry standard 28 gauge lancets. In addition, the system's Advanced Glide™ Control System precisely guides the lancet in a swift, straight motion that reduces vibration for a smoother lancing experience. It also features seven adjustable depth settings to allow for shallower fingertip punctures that may be less painful.
The OneTouch Delica Lancing System is now available at pharmacies and retailers nationwide and is designed to work exclusively with the new, small gauge OneTouch Delica Lancets. The OneTouch Delica Lancing System has an estimated retail price of $19.99 and includes 10 lancets. 100-count OneTouch Delica Lancets have an estimated retail price of $15.99. The system and lancets are covered by Medicare Part B and most private insurance plans.
LifeScan, Inc., a leading maker of blood glucose monitoring products, is dedicated to creating a world without limits for people with diabetes. For information on diabetes care and OneTouch products and services, visit www.OneTouchDiabetes.com.
(1) Response from study subjects when asked to compare the OneTouch® Delica™ lancing system to their current lancing system.
(2) LifeScan Lost Customer Study, March 2008.
* Dr. Steinberg is compensated for his services as a consultant to LifeScan, Inc.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.